Side-effects of banned drug Nimesulide still reported in children: Report

Nimesulide is used to relieve pain, inflammation, and fever. It belongs to a class of painkillers called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) .

Livemint
Published5 Oct 2024, 12:12 PM IST
Nimesulide is used to relieve pain, inflammation, and fever.
Nimesulide is used to relieve pain, inflammation, and fever.(AFP)

A report claimed on Saturday that the side effects of painkiller Nimesulide are still being reported to the drug monitoring agency despite the medicine's ban 13 years ago. This hints at the possibility that the drug is still being prescribed.

"Following these findings, monitoring agency Indian Pharmacopeia Commission [IPC] has urged drug manufacturers to 'sensitise' paediatricians and other healthcare professionals about the importance of not prescribing this drug to children," News 18 reported on Saturday.

Also Read | ‘Laddus’ to drugs, adulteration is a national crisis

Nimesulide is used to relieve pain, inflammation, and fever. It belongs to a class of painkillers called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) . In 2011, the Ministry of Health and Family Welfare banned the manufacture, sale and distribution of ‘nimesulide' formulations for human use in children below 12 years of age.

"Nimesulide formulations in children below 12 years of age - Nimesulide containing products are not permitted in many countries in children under 12 years of age. The drug has been considered to be hepatotoxic and children are considered more susceptible to hepatotoxicity," a statement issued by the Union health minister had stated.

Also Read | Cancer-causing agents found in 12 cakes of Bengaluru bakery, warning issued

Meanwhile, a research published in BMJ journal in 2003 said, "A plethora of scientific data show that nimesulide should not be used as the primary mode of treatment as an antipyretic or analgesic, especially in children, for whom much better and safer choices are available," a research published in the BMJ journal in 2003 stated.

However, despite the ban, the Pharmacovigilance Program of India (PvPI) is receiving complaints. The PvPI monitors and collects information about adverse drug reactions (ADRs) and adverse events associated with pharmaceutical products.

Also Read | Alert! Paracetamol, Vitamin D3 tablets and 46 other drugs fail quality test

A letter accessed by News18 showed the Indian Pharmacopeia Commission (IPC) – which runs the Pharmacovigilance Program of India (PvPI) program – has decided to start ‘sensitisation’ of healthcare professionals and consumers to not use Nimesulide drugs in children under 12 years of age.

The letter dated October 1 reportedly read, “PvPI has been still receiving some reports of Nimesulide induced adverse drug reactions from marketing authorisation holders under PvPI.”

It further requested action in the interest of “paediatric patient safety”. It urged all concerned healthcare professionals and consumers not to prescribe or use the Nimesulide formulations in children under 12 years of age.

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:5 Oct 2024, 12:12 PM IST
Business NewsNewsIndiaSide-effects of banned drug Nimesulide still reported in children: Report

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    150.90
    03:56 PM | 7 NOV 2024
    -2.7 (-1.76%)

    Bharat Electronics share price

    300.20
    03:58 PM | 7 NOV 2024
    -1.65 (-0.55%)

    Bank Of Baroda share price

    262.90
    03:29 PM | 7 NOV 2024
    0.3 (0.11%)

    Indian Oil Corporation share price

    144.20
    03:59 PM | 7 NOV 2024
    -0.45 (-0.31%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Apollo Hospitals Enterprise share price

    7,424.60
    03:40 PM | 7 NOV 2024
    454.75 (6.52%)

    Welspun Corp share price

    798.00
    03:29 PM | 7 NOV 2024
    24.55 (3.17%)

    City Union Bank share price

    181.50
    03:29 PM | 7 NOV 2024
    2 (1.11%)

    Federal Bank share price

    206.00
    03:57 PM | 7 NOV 2024
    1.2 (0.59%)
    More from 52 Week High

    Hindalco Industries share price

    648.35
    03:51 PM | 7 NOV 2024
    -59.9 (-8.46%)

    Trent share price

    6,498.45
    03:59 PM | 7 NOV 2024
    -454.6 (-6.54%)

    Glenmark Pharmaceuticals share price

    1,658.00
    03:29 PM | 7 NOV 2024
    -110.95 (-6.27%)

    Blue Star share price

    1,776.95
    03:56 PM | 7 NOV 2024
    -101.8 (-5.42%)
    More from Top Losers

    Swan Energy share price

    535.60
    03:29 PM | 7 NOV 2024
    39.05 (7.86%)

    KEC International share price

    1,050.30
    03:40 PM | 7 NOV 2024
    74.8 (7.67%)

    Apollo Hospitals Enterprise share price

    7,424.60
    03:40 PM | 7 NOV 2024
    454.75 (6.52%)

    FSN E-Commerce Ventures share price

    192.90
    03:29 PM | 7 NOV 2024
    11.45 (6.31%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      78,575.00-1,790.00
      Chennai
      78,581.00-1,790.00
      Delhi
      78,733.00-1,790.00
      Kolkata
      78,585.00-1,790.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      100.80/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts